Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.

This bill requires health insurance plans in New Jersey to cover oral anticancer medications on the same financial terms as intravenous (IV) anticancer medications. It directly affects cancer patients enrolled in health insurance plans governed by hospital service, medical service, health service, or individual health insurance policies. The key provision bans additional upfront costs, copayments, deductibles, or coinsurance for oral medications that aren't applied to IV medications, ensuring patients pay no more for oral treatments than for IV ones. Plans cannot offset this requirement by increasing patient costs for any covered anticancer drugs. The law applies to all relevant insurance contracts renewed or issued after its effective date.